BIM
CTIC

BlackRock Investment Management’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

BlackRock Investment Management’s Portfolio CTIC Stock Details CTIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-84,700
Closed -$450K – 4264
2016
Q1 		$450K Buy
84,700
+19,272
+29% +$154K ﹤0.01% 2935
2015
Q4 		$805K Buy
65,428
+8,422
+15% +$112K ﹤0.01% 2747
2015
Q3 		$832K Sell
57,006
-1,345
-2% -$23.2K ﹤0.01% 2733
2015
Q2 		$1.14M Buy
58,351
+14,577
+33% +$281K ﹤0.01% 2670
2015
Q1 		$792K Buy
43,774
+1,360
+3% +$30.6K ﹤0.01% 2681
2014
Q4 		$1M Buy
42,414
+3,248
+8% +$75.1K ﹤0.01% 2551
2014
Q3 		$948K Buy
39,166
+291
+0.7% +$7.57K ﹤0.01% 2568
2014
Q2 		$1.09M Buy
38,875
+2,763
+8% +$83K ﹤0.01% 2541
2014
Q1 		$1.23M Buy
36,112
+884
+3% +$30.2K ﹤0.01% 2365
2013
Q4 		$673K Buy
35,228
+3,315
+10% +$60.3K ﹤0.01% 2788
2013
Q3 		$517K Buy
31,913
+2,894
+10% +$33.5K ﹤0.01% 2913
2013
Q2 		$305K Buy
+29,019
New +$340K ﹤0.01% 3081

Other funds holding CTIC

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PP
Paloma Partners Greenwich, Connecticut $1.36B AUM 249.29% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

BlackRock Investment Management's CTIC Position: Q2 2016 in Review

BlackRock Investment Management sold out of CTI BioPharma Corp. (DE) Common Stock (CTIC) in Q2 2016, closing a stake of 84,700 shares — an estimated $450K sold.

BlackRock Investment Management first reported a position in CTIC in Q2 2013 and held it in 12 quarters. The position peaked at $1.23M in Q1 2014. 67 funds tracked by Wall St. Rank hold CTIC as of Q2 2016.

  • BlackRock Investment Management reported no remaining CTI BioPharma Corp. (DE) Common Stock position as of Q2 2016 after selling out during the quarter.
  • BlackRock Investment Management sold 84,700 CTI BioPharma Corp. (DE) Common Stock shares in Q2 2016, an estimated $450K.
  • BlackRock Investment Management first reported a position in CTI BioPharma Corp. (DE) Common Stock in Q2 2013 and held it in 12 quarters.
  • BlackRock Investment Management's CTI BioPharma Corp. (DE) Common Stock position peaked at $1.23M in Q1 2014.
  • 67 funds tracked by Wall St. Rank held CTI BioPharma Corp. (DE) Common Stock as of Q2 2016.

Based on BlackRock Investment Management's 13F filing for Q2 2016, filed 10 Aug 2016.